BIOMAT Database Logo BIOMAT Database Logo

3D QSAR analysis of 2-(substituted aryl)-thiazolidine-4-carboxamides as potent antitubercular agents. 2014

Kurre Purna Nagasree, and Muthyala Murali Krishna Kumar, and Yejella Rajendra Prasad, and Dharmarajan Sriram, and Perumal Yogeeswari

Thiazolidine-4-carboxylic acid derivatives were recognized recently for their potent antitubercular activity. A total of sixty four thiazolidine derivatives published in the recent times were collected and 3D QSAR models were developed, using CoMFA and COMSIA with high predictability. Later, we selected three new molecules, recently synthesized in our lab and evaluated them using the developed QSAR models. The in vitro antitubercular activity (MIC) obtained for these new molecules is in agreement with the predicted values (pMIC).

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D000995 Antitubercular Agents Drugs used in the treatment of tuberculosis. They are divided into two main classes: "first-line" agents, those with the greatest efficacy and acceptable degrees of toxicity used successfully in the great majority of cases; and "second-line" drugs used in drug-resistant cases or those in which some other patient-related condition has compromised the effectiveness of primary therapy. Anti-Tuberculosis Agent,Anti-Tuberculosis Agents,Anti-Tuberculosis Drug,Anti-Tuberculosis Drugs,Antitubercular Agent,Antitubercular Drug,Tuberculostatic Agent,Tuberculostatic Agents,Antitubercular Drugs,Agent, Anti-Tuberculosis,Agent, Antitubercular,Agent, Tuberculostatic,Anti Tuberculosis Agent,Anti Tuberculosis Agents,Anti Tuberculosis Drug,Anti Tuberculosis Drugs,Drug, Anti-Tuberculosis,Drug, Antitubercular
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D053778 Thiazolidines Reduced (protonated) form of THIAZOLES. They can be oxidized to THIAZOLIDINEDIONES. Thiazolidine
D021281 Quantitative Structure-Activity Relationship A quantitative prediction of the biological, ecotoxicological or pharmaceutical activity of a molecule. It is based upon structure and activity information gathered from a series of similar compounds. Structure Activity Relationship, Quantitative,3D-QSAR,QSAR,QSPR Modeling,Quantitative Structure Property Relationship,3D QSAR,3D-QSARs,Modeling, QSPR,Quantitative Structure Activity Relationship,Quantitative Structure-Activity Relationships,Relationship, Quantitative Structure-Activity,Relationships, Quantitative Structure-Activity,Structure-Activity Relationship, Quantitative,Structure-Activity Relationships, Quantitative

Related Publications

Kurre Purna Nagasree, and Muthyala Murali Krishna Kumar, and Yejella Rajendra Prasad, and Dharmarajan Sriram, and Perumal Yogeeswari
Substituted hydrazinecarbothioamide as potent antitubercular agents: synthesis and quantitative structure-activity relationship (QSAR).
April 2010, Bioorganic & medicinal chemistry letters,
Kurre Purna Nagasree, and Muthyala Murali Krishna Kumar, and Yejella Rajendra Prasad, and Dharmarajan Sriram, and Perumal Yogeeswari
Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxamides.
October 2008, European journal of medicinal chemistry,
Kurre Purna Nagasree, and Muthyala Murali Krishna Kumar, and Yejella Rajendra Prasad, and Dharmarajan Sriram, and Perumal Yogeeswari
QSAR and molecular shape analysis of aryl-substituted alanine analogs as antigelling agents.
November 1989, Journal of theoretical biology,
Kurre Purna Nagasree, and Muthyala Murali Krishna Kumar, and Yejella Rajendra Prasad, and Dharmarajan Sriram, and Perumal Yogeeswari
3D QSAR study on substituted 1, 2, 4 triazole derivatives as anticancer agents by kNN MFA approach.
December 2023, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
Kurre Purna Nagasree, and Muthyala Murali Krishna Kumar, and Yejella Rajendra Prasad, and Dharmarajan Sriram, and Perumal Yogeeswari
Synthesis, antitubercular evaluation and 3D-QSAR study of N-phenyl-3-(4-fluorophenyl)-4-substituted pyrazole derivatives.
January 2012, Bioorganic & medicinal chemistry letters,
Kurre Purna Nagasree, and Muthyala Murali Krishna Kumar, and Yejella Rajendra Prasad, and Dharmarajan Sriram, and Perumal Yogeeswari
Quantitative structure activity relationship (QSAR) modeling study of some novel thiazolidine 4-one derivatives as potent anti-tubercular agents.
June 2023, Journal of receptor and signal transduction research,
Kurre Purna Nagasree, and Muthyala Murali Krishna Kumar, and Yejella Rajendra Prasad, and Dharmarajan Sriram, and Perumal Yogeeswari
Novel 4-substituted 2-piperazinylquinazolines as potent anticonvulsive and antihypoxic agents.
May 1990, Chemical & pharmaceutical bulletin,
Kurre Purna Nagasree, and Muthyala Murali Krishna Kumar, and Yejella Rajendra Prasad, and Dharmarajan Sriram, and Perumal Yogeeswari
4-Substituted picolinohydrazonamides as a new class of potential antitubercular agents.
March 2020, European journal of medicinal chemistry,
Kurre Purna Nagasree, and Muthyala Murali Krishna Kumar, and Yejella Rajendra Prasad, and Dharmarajan Sriram, and Perumal Yogeeswari
Synthesis of 3-aryl-2-substituted-4(3H)-quinazolines as potential antimicrobial agents.
April 1990, Farmaco (Societa chimica italiana : 1989),
Kurre Purna Nagasree, and Muthyala Murali Krishna Kumar, and Yejella Rajendra Prasad, and Dharmarajan Sriram, and Perumal Yogeeswari
Synthesis and QSAR studies of 4-substituted phenyl-2,6-dimethyl-3, 5-bis-N-(substituted phenyl)carbamoyl-1,4-dihydropyridines as potential antitubercular agents.
August 2001, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!